2 assets in Cushing Disease Due To Pituitary Adenoma

Therapeutic assets addressing Cushing Disease Due To Pituitary Adenoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cabergoline Cushing Disease Due To Pituitary Adenoma	University of Basrah	P4	BB (69)
Osilodrostat Cushing Disease Due To Pituitary Adenoma	University of Basrah	P4	BB (65)